• International leaders share what makes the ACR/ARHP Annual Meeting special

    International leaders share what makes the ACR/ARHP Annual Meeting special

    For those attending from overseas, the ACR/ARHP Annual Meeting offers an invaluable opportunity to connect with a global community of rheumatology professionals and thought leaders from around the world.

  • Tips on getting the most out of the Annual Meeting abstracts

    Tips on getting the most out of the Annual Meeting abstracts

    Big data has changed how attendees interact with all of the abstracts presented during the Annual Meeting. Find out how to navigate the giant sea of information now available, whether it’s an oral or poster presentation.

  • Biosimilars having little impact on U.S. market

    Biosimilars having little impact on U.S. market

    Biosimilars are a great idea whose time has not come, at least not in the United States. “The whole rationale behind biosimilars is that they would be as effective, as […]

  • Virtual reality shows promising results for pain management

    Virtual reality shows promising results for pain management

    With an ongoing opioid epidemic spreading across the United States, clinicians are increasingly looking for alternative pain management strategies. Virtual reality therapy has gained the attention of clinicians across a […]

  • TNF inhibition offers a first step toward RA cure

    TNF inhibition offers a first step toward RA cure

    TNF blockers are big science and big business. Three TNF inhibitors are among the top seven best-selling drugs in the world.
 “If you thought that experimental medicine doesn’t lead to […]

  • Study points to possible treatment for Sjögren’s syndrome

    Study points to possible treatment for Sjögren’s syndrome

    Results from a proof-of-concept study presented Monday during Plenary Session II suggest that CFZ533, a blocking, non-depleting anti-CD40 antibody, may offer a new treatment modality in clinically active primary Sjögren’s […]

  • IL-6 shows promise in treating RA, other inflammatory diseases

    IL-6 shows promise in treating RA, other inflammatory diseases

    IL-6 is emerging as a key therapeutic target in chronic inflammatory diseases, including rheumatoid arthritis (RA), cancer, coronary heart disease, and Crohn’s disease. In RA, inhibiting IL-6 by blocking the […]

  • Pharmacy specialists offer benefits for patients, clinicians at pediatric clinic

    Pharmacy specialists offer benefits for patients, clinicians at pediatric clinic

    When specialists work together, clinicians and patients alike can experience the positive effects. Such has been the case for a pediatric specialty clinic that has incorporated a specialty pharmacy into […]

  • Mapping a better path to OA treatment

    Mapping a better path to OA treatment

    On the path to improved osteoarthritis (OA) management, how good is today’s map? During this year’s ARHP Distinguished Lecture: Moving Toward Better Osteoarthritis Management, Kelli D. Allen, PhD, with the […]

  • Experts to consider diagnostic dilemmas in myositis

    Experts to consider diagnostic dilemmas in myositis

    When treating patients with myositis, rheumatologists must be cognizant of several considerations that could have severe — even fatal — consequences if left untreated. The 90-minute clinical symposium Hot Topics […]